GENMAB (GE9 BE) stock market data APIs
€283.196
-10.74(-3.8%)
as of October 13, 2025
Try our APIs with
free plan!
GENMAB Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for GE9.BE.
Prev. Close
283.196
Open
272.4523
High
283.196
Low
272.4523
52 wk Range
155.8-286.3
Market Cap
22 148 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get GENMAB data using free add-ons & libraries
Get GENMAB Fundamental Data
GENMAB Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
GENMAB News
New
Genmab (CPSE:GMAB) Valuation Insights Following Recent Share Price Climb
Genmab (CPSE:GMAB) shares have delivered a solid stretch of performance over the past month, rising 14%. Investors are taking note as the company continues to report steady annual revenue and net inco...
Is Genmab’s Rally Justified After Strong Quarterly Results in 2025?
Thinking about whether to buy, sell, or simply watch Genmab's stock? You are not alone. With a price that has closed at 2044.0 and a history of some wild ups and downs, Genmab keeps showing up on watc...
Bristol Myers Squibb Buys Private Biotech for $1.5 Billion. The Deal Wave Keeps Going.
The recent cavalcade of biotech deals continued Friday morning, when Bristol Myers Squibb said it had agreed to pay $1.5 billion to acquire Orbital Therapeutics, an early-stage, privately held biotech...
Bispecific Antibodies Market - Global Forecast 2025-2032, Profiles of Key Players - F. Hoffmann-La Roche, Amgen, Janssen Biotech, Pfizer, AbbVie, Regeneron, MacroGenics, AstraZeneca, Merck, and Genmab
Company Logo The bispecific antibodies market presents key opportunities in oncology, autoimmune, and infectious diseases, driven by rapid technological advancements and strategic collaborations. Reg...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
